TF and Sepsis: A drug developed to block TF activity which is a conjugate of the natural inhibitor of the TF pathway – tissue factor pathway inhibitor – reduced mortality in a primate model of sepsis [83], but did not improve outcome in a large intervention trial of sepsis in humans [84].